Skip to main content

D. E. Shaw & Co., Inc.

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1009207 New York, NY

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$21,717,418
-$2,977,863 QoQ
Shares Held
1,182,222
-6.4% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 215 holders
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. VRDN ranks #46 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,717,418 1,182,222
2026-03-31 $24,695,281 1,262,540
2025-12-31 $31,142,312 1,000,717
2025-03-31 $1,097,042 81,383
2024-12-31 $8,474,481 442,070
2024-09-30 $3,141,024 138,067
2022-12-31 $9,877,858 338,167
2022-09-30 $12,885,920 628,275
2022-06-30 $8,783,110 759,128
2022-03-31 $14,479,426 783,095
2021-12-31 $15,116,399 764,613
2021-09-30 $11,852,718 720,530
2021-06-30 $13,175,622 720,373
2021-03-31 $3,150,035 188,512